v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
General and administrative $ 1,733,321 $ 1,406,160
Research and development 2,552,947 2,660,237
Total operating expenses 4,286,268 4,066,397
Loss from operations (4,286,268) (4,066,397)
Interest income 133,782 22,421
Other income (expense), net 284,721 (77,798)
NET LOSS $ (3,867,765) $ (4,121,774)
Net loss per share of common shares, basic and diluted $ (0.36) $ (0.38)
Weighted-average number of common shares outstanding, basic and diluted 10,857,040 10,875,777

Source